Showing results (351-360 of 456) with videos related to
Sort By:
Pageof 46
Hepatology International|August 13, 2021
First-in-Asian double-blind randomized trial to assess the efficacy and safety of insulin sensitizer in nonalcoholic steatohepatitis patientsJee-Fu Huang, Chia-Yen Dai, Chung-Feng Huang, et al.Journal of Gastroenterology and Hepatology|July 24, 2025
Steatotic Liver Disease-Related Polygenetic Risk Score Prediction of Hepatocellular Carcinoma in Nucleotide/Nucleoside Analog-Treated Chronic Hepatitis BTyng-Yuan Jang, Chih-Wen Wang, Po-Cheng Liang, et al.The Lancet. Gastroenterology & Hepatology|April 14, 2017
Tenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of patients with HBeAg-negative chronic hepatitis B virus infection: a randomised, double-blind, phase 3, non-inferiority trialMaria Buti, Edward Gane, Wai Kay Seto, et al.Hepatology (Baltimore, Md.)|January 17, 2013
Sustained hepatitis C virus clearance and increased hepatitis B surface antigen seroclearance in patients with dual chronic hepatitis C and B during posttreatment follow-upMing-Lung Yu, Chuan-Mo Lee, Chi-Ling Chen, et al.Annals of Internal Medicine|December 4, 2013
Pegylated interferon-α2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 1 receiving hemodialysis: a randomized trialChen-Hua Liu, Chung-Feng Huang, Chun-Jen Liu, et al.Oncotarget|February 5, 2017
Risk of hepatitis C virus related hepatocellular carcinoma between subjects with spontaneous and treatment-induced viral clearanceChung-Feng Huang, Ming-Lun Yeh, Ching-I Huang, et al.Oncotarget|August 20, 2016
Dynamics of PBMC gene expression in hepatitis C virus genotype 1-infected patients during combined peginterferon/ribavirin therapyMing-Ying Lu, Ching-I Huang, Ming-Yen Hsieh, et al.Medicine|June 1, 2017
Identification of groups with poor cost-effectiveness of peginterferon plus ribavirin for naïve hepatitis C patients with a real-world cohort and databasePei-Chien Tsai, Ta-Wei Liu, Yi-Shan Tsai, et al.World Journal of Gastroenterology|March 17, 2025
Mitochondrial mt12361A>G increased risk of metabolic dysfunction-associated steatotic liver disease among non-diabetesMing-Ying Lu, Yu-Ju Wei, Chih-Wen Wang, et al.The American Journal of Gastroenterology|August 10, 2023
Long-Term Treatment With Tenofovir Alafenamide for Chronic Hepatitis B Results in High Rates of Viral Suppression and Favorable Renal and Bone SafetyHenry L Y Chan, Maria Buti, Young-Suk Lim, et al.Pageof 46